Previous Article | Next Article ![]()
Infection and Immunity, February 2000, p. 570-576, Vol. 68, No. 2
Groupe d'Etude des Interactions
Hôte-Parasite, Laboratoire de Parasitologie-Mycologie,
Faculté de Pharmacie, 49000 Angers,1 and
Laboratoire de Parasitologie-Mycologie, UFR des Sciences
Médicales, Nantes,2 France
Received 1 July 1999/Returned for modification 28 September
1999/Accepted 11 November 1999
The in vivo interactions of platelets with Candida
species yeast cells were investigated in a murine model. Mice were
injected intravenously via the lateral caudal vein, and blood drawn by periorbital puncture was collected in phosphate-buffered
saline-formaldehyde to avoid in vitro platelet activation. The study
of the clearance of blastoconidia of Candida albicans and
Candida glabrata showed that these cells disappeared
quickly from the bloodstream. Microscopic observation of blood samples,
stained by Calcofluor white or May Grunwald Giemsa, demonstrated the
rapid attachment of platelets to fungal elements of all the
Candida spp. tested. The attachment of murine platelets to
C. albicans cells, observed by scanning electron
microscopy, revealed morphological changes. The platelets lost their
discoid shape, generated pseudopodia, and flattened against the yeast
cells. The reversibility of platelet binding to C. albicans
by chelating agents suggests a cation-dependent link. In contrast, the
fixation of C. glabrata and Candida tropicalis was not modified by chelating agents. The mechanisms involved in the in
vivo adherence of platelets to Candida cells may therefore differ according to the species of Candida.
Disseminated Candida
infections involve the translocation of Candida cells
through the blood circulation. In the bloodstream, the fungus may
interact with various (soluble) proteins such as fibrinogen
(3), fibronectin (16, 28), complement, and other plasma components (8, 9); with the vascular endothelium (27); and with glycoproteins of the subendothelial
extracellular matrix (26) such as collagen and laminin
(4, 17). It may also interact with blood cells such as
neutrophils, which are usually considered to be the primary effective
cells against Candida yeast (6). Platelets, known
to be critical mediators of homeostasis and blood coagulation, have
recently been implicated in the metastatic processes of tumor cells
(2, 12, 30) and in the pathogenesis of infectious diseases
(34).
Several in vitro studies have suggested that platelets interact with
Candida cells. Maish and Calderone demonstrated the
adherence of Candida albicans to fibrin-platelet clots
(18, 19). The same group showed that cell wall fragments of
C. albicans were able to aggregate platelets
(29). Previously, we reported that resting platelets adhere
to C. albicans germ tubes and that this attachment is
associated with morphological changes (24, 25). Klotz et al.
studied the adherence of C. albicans to the endothelium and
to the subendothelial extracellular matrix and demonstrated that the
interaction between yeast and platelets occurred after platelet
aggregation (14, 15). However, although these authors detected platelet aggregation with yeast cytosol, they were unable to
produce platelet aggregation with viable whole yeast. A recent study by
Willcox et al. (30) concludes that C. albicans,
unlike all other species, is unable to aggregate platelets. This study also demonstrated the ability of platelets to kill some
Candida spp. but not C. albicans. However, Yeaman
et al. showed that platelets are activated by Candida
species to secrete platelet microbicidal peptides and that these
peptides are active against the Candida organisms (32,
33, 35).
In vivo interactions between Candida species and platelets
have been only partially studied. Holder and Nathan (11)
observed that injection of sonic cell extract of Candida
into mice produced platelet aggregation. In a rabbit model, Calderone
et al. (5) studied endocarditis elicited by traumatic
destruction of aortic valves and demonstrated the close apposition of
Candida cells and platelets in the lesion. Demonstration of
Candida in blood smears from patients has been reported, and
Kates et al. (13) showed platelets in close association with
yeast. Platelet anti-Candida activity has been described and
has been shown to play a role in the severity of experimental C. albicans endocarditis (33).
Although platelets are considered a factor in the pathogenesis of
candidiasis, it is unclear whether these cells promote or limit the
progression of the disease. We describe an in vivo procedure for the
study of the adherence of mouse platelets to Candida cells. The amount of platelet binding to Candida species was
measured by fluorescence microscopy after coloration by Calcofluor
white. The results obtained demonstrate an interaction between
platelets and all Candida species. In addition, the fixation
of platelets to the circulating blastoconidia of C. albicans
in vivo was confirmed by scanning electron microscopy (SEM), which
showed that the attachment to the platelets was associated with
morphological changes.
Organisms and culture conditions.
C. albicans 1066 (ATCC 66369), originally isolated from a case of septicemia, was used
throughout this work. Two clinical isolates of C. albicans
and isolates of Candida spp. C. glabrata, C. krusei, C. tropicalis, C. parapsilosis, C. kefyr, and C. guilliermondii were obtained from the Mycological Laboratory of
the Faculty of Medicine, Angers, France. All strains were maintained by
subculture on Sabouraud dextrose agar slants (Merck, Darmstadt,
Germany) at 37°C for 24 h twice a month.
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Adherence of Platelets to Candida
Species In Vivo
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
yeast
nitrogen base [Fisher Scientific]) containing 2% glucose and 5
ammonium sulfate (YNB-G-SA) for 24 h at 37°C, pH 4.5. In some
experiments, germ tubes were obtained by incubation of blastoconidia
for 3 h in YNB-G-SA at 37°C and pH 7. Cells were harvested by
centrifugation (10 min, 500 × g), washed three times
in 0.15 M NaCl, and finally resuspended in this buffer at the required
concentration after a hemacytometer count.
Mice. Female, outbred Swiss mice, 6 to 8 weeks old, weighing 18 to 20 g (Centre d'Elevage Déprés-France) were maintained under conventional conditions before experimentation. Mice were injected intravenously via the lateral vein, and blood was drawn by periorbital puncture immediately after the mice were killed by cervical dislocation. Blastoconidia of all the Candida spp. studied were suspended in 0.1 ml of 0.15 M NaCl for inoculation.
Clearance of C. albicans and C. glabrata blastoconidia from the bloodstream. One hundred microliters of C. albicans or C. glabrata blastoconidia suspensions (2 × 107 cells) was injected into the lateral tail veins of mice. One, 3, and 15 min after injection, the mice were bled by periorbital puncture, and 20 µl of the blood was immediately mixed with 250 µl of distilled water. After 5 min the erythrocytes were lysed, and the blastoconidia were labeled by mixing 1 volume of 0.1 mM fluorescent brightener (Calcofluor white [Sigma, St. Louis, Mo.]) in phosphate-buffered saline (PBS; 0.15 M, pH 7.2) with 5 volumes of sample. The enumeration of the blastoconidia was realized by a direct hemacytomer count under fluorescence microscopy using a Nikon incident-light fluorescence microscope with an excited filter with peak transmission at 365 nm and a barrier filter that transmitted light at wavelengths >420 nm.
Interactions of Candida spp. cells with platelets in vivo. For the adherence assays, the mice were injected intravenously via the lateral tail vein with 5 × 107 to 7 × 107 Candida spp. blastoconidia or C. albicans germ tubes. After 3 min, blood was drawn and 20 µl of blood was immediately mixed in a plastic tube with 1 ml of PBS or PBS containing 3.3 mM formaldehyde to prevent in vitro platelet activation. In experiments to study the role of divalent cations, blood was collected in PBS containing 10 mM EDTA or 10 mM EGTA or 0.13 M sodium citrate. For negative controls, 20 µl of blood from an uninfected mouse was mixed with all the above buffers supplemented with 5 × 105 blastoconidia. The blood samples were incubated in the buffers for 1 to 60 min prior to examination by photonic fluorescence microscopy following yeast labeling with Calcofluor white as described above.
In some experiments, mice were bled 1, 3, and 15 min after inoculation and the blood samples were treated with Calcofluor white or the May Grunwald Giemsa stain (MGG [Ral, Paris, France]) before examination by photonic microscopy. For the SEM study of platelet attachment to C. albicans ATCC 66369 cells, 5 × 107 blastoconidia were inoculated. After 15 min, 500 to 600 µl of blood was collected in 25 ml of PBS and passed immediately through a filter (10-µm pore size; MSI, Westboro, Mass.) to remove the erythrocytes. Then the filter was washed once again with 25 ml of PBS and set in a sterile tube containing 1 ml of 0.15 M NaCl. Cells were removed by gentle agitation, the filter was discarded, and the preparation containing the holding cells was fixed in 2.5% glutaraldehyde, postfixed in 2% OsO4, dried at the critical point, coated with gold-palladium, and examined with a JEOL JSM 35 microscope as described by Miegeville and Morin (21).Statistical analyses. For each experiment, at least three mice were inoculated and each bloodletting was divided into three tubes. Statistical significance was determined by using the paired t test. All comparisons were two sided, and a P value of <0.05 was considered significant.
| |
RESULTS |
|---|
|
|
|---|
Clearance of C. albicans ATCC 66369 and C. glabrata blastoconidia from the bloodstream. Blastoconidia (2 × 107) were inoculated into the mice by intravenous injection. One, 3, and 15 min after inoculation, blastoconidia were numbered after staining by Calcofluor white. Figure 1 indicates that blastoconidia of C. albicans disappeared more quickly from the bloodstream than did C. glabrata cells. To illustrate, 1 min after inoculation, with the blood volume of mice being approximately 3 ml, the percentages of remaining circulating blastoconidia of C. albicans and C. glabrata were estimated at 3 and 22.5%, respectively, of the blastoconidia initially injected (P < 0.001). Three minutes after inoculation, the decrease of circulating yeast cells became more pronounced, leading to the disappearance of 98 and 89% of the blastoconidia initially injected for C. albicans and C. glabrata, respectively (P <0.01).
|
Choice of the blood buffer for the studies of interaction between
platelets and blastoconidia.
As the time between the taking and
the observation of blood may vary, the composition of the buffer and
the time of incubation of blood in this buffer, ensuring no
modification of the in vivo interaction of platelets with yeast, were
determined for C. albicans ATCC 66369 and C. glabrata (Table 1).
|
|
Interaction between C. albicans and platelets: results of photonic microscopy. When blood from mice inoculated with blastoconidia or germ tubes of C. albicans ATCC 66369 was observed in the presence of Calcofluor white with a UV microscope, it was very easy to locate yeast cells (Fig. 2A, C, E, and G). Platelets rapidly attached to germ tubes (Fig. 2F) or blastoconidia (Fig. 2B, D, and H): 1 to 3 min after inoculation yeast cells fixed one or two platelets or formed microaggregates (Fig. 2A to F) with platelets. Fifteen to 30 min after inoculation, only a few blastoconidia (Fig. 2G and H) or germ tubes (data not shown) were observed, usually associated with large aggregates of platelets. Quantitative studies showed that whatever the strain of C. albicans used (ATCC 66369 or clinical isolates), the proportion of blastoconidia bound to platelets was high (90 to 95%) (Table 2). The attachment of platelets to fungal elements was confirmed when blood smears stained by MGG were examined by photonic microscopy (Fig. 3A and B). Platelets were seen in close association with blastoconidia (Fig. 3A) or germ tubes (data not shown). However the distribution of the yeast on the blood smear was heterogeneous: free yeast cells or yeast cells with a crown of platelets were observed in the center of the smear, whereas yeast cells associated with large aggregates of platelets were observed at the front edge and sides of the smears.
|
|
Interactions between C. albicans and platelets: results of SEM. The binding of platelets to blastoconidia or germ tubes of C. albicans ATCC 66369 was observed 15 min after inoculation. The results of SEM (Fig. 4) show yeast cells in aggregates of platelets (Fig. 4C) and platelets attached to fungal elements (Fig. 4A, B, and D). After fixation on the surface on the fungus, the platelets lose their discoid shape, producing spikes or pseudopodia (Fig. 4A and B). Sometimes the platelets flatten and spread over the blastoconidia (Fig. 4A) or germ tubes (Fig. 4D).
|
Interactions between Candida spp. and platelets. The interactions between mouse platelets and several common species of Candida were studied in vivo by photonic microscopy. The results show that the platelets are able to bind to blastoconidia of all strains (Table 2). As we observed for C. albicans in blood smears or after staining with Calcofluor white, the platelets were seen in close association with circulating blastoconidia. To illustrate, Fig. 3C and D show about eight platelets attached to a blastoconidium of C. parapsilosis and its bud after staining with Calcofluor white and Fig. 3B shows two blastoconidia of C. krusei associated with large aggregates of platelets at the edge of a blood smear.
Role of divalent cations in the interaction between platelet and yeast. When blood from mice inoculated with C. albicans ATCC 66369 was collected in PBS-EDTA or in PBS-sodium citrate, 30 min after incubation in these buffers, there was a small but significant decline (P < 0.02) in the percentages of blastoconidia bound to the platelets (PBS-EDTA, 64.5% ± 3.1%; PBS-citrate, 59.2% ± 2.7%) compared to the percentages observed after 5 min of incubation (PBS-EDTA, 92% ± 3.2%; PBS-citrate, 85.8% ± 3.1%). After 30 min of incubation in PBS-EGTA the percentage of blastoconidia bound to platelets was greatly depressed (20.2% ± 1.3%; P < 0.001). Similarly, the percentages of C. albicans bound to platelets decreased sharply after 60 min (PBS-EDTA, 44.3% ± 3.5%; P < 0.001; PBS-citrate, 42.3% ± 1.9%; P < 0.001).
For C. glabrata and C. tropicalis, whatever the buffer used or the time of incubation, no statistically significant differences in the reduction of the proportion of yeast cells binding to platelets were observed. To illustrate, the percentages of C. tropicalis bound to platelets after incubation with EDTA were 96% ± 0.8% after 5 min and 90.8% ± 1.7% after 60 min.| |
DISCUSSION |
|---|
|
|
|---|
In the bloodstream, platelets circulate in the form of disk-shaped cell fragments that do not normally interact with the vascular endothelial lining. When the endothelial lining is damaged or the blood vessel is injured, platelets adhere to subendothelial components such as collagen and microfibrils. This adherence elicits the secondary activation of the platelets for the generation of a hemostatic plug. In vitro, the addition of collagen or ADP to blood or platelet-rich plasma (PRP) induces the activation and aggregation of platelets. To aggregate to each other, the platelets in the bloodstream or in PRP must be activated and express fibrinogen receptors.
Apart from the fact that platelets have a vital function in hemostats, they may have a role in the pathogenesis of tumoral metastases (20) and in the dissemination of bacteria (7, 10) or parasites (1, 23, 36). There is circumstantial evidence that platelets may interact with Candida (15, 24, 25, 29). Although numerous studies have investigated the ability of yeast cells and yeast cell components to aggregate platelets in PRP (22, 29, 30), little is known concerning the adherence of platelets to yeast cells, which could be a critical initial event in inducing the activation and aggregation of platelets.
In the present study, we have used a murine model to study the abilities of different species of Candida to bind platelets in vivo. The data presented here indicate that after injection of blastoconidia into mice the rate of clearance of C. albicans from the bloodstream was high, leading to the disappearance of 97% of the inoculated cells within the first minute of incubation. In contrast, the rate of clearance observed with C. glabrata was eightfold lower.
Microscopic observation of blood samples stained by Calcofluor white or MGG showed rapid binding of platelets to blastoconidia of all Candida spp. The attachment of murine platelets onto C. albicans cells observed by SEM was associated with morphological changes. Platelets lost their discoid shape, generated spikes or pseudopodia, and flattened against the yeast cells. Some fungal elements were trapped in platelet aggregates. These findings suggest an activation of the platelets. Our observations support earlier results obtained by an in vitro procedure for the study of the interaction between washed resting human platelets and C. albicans germ tubes (24, 25). These results have been confirmed by Yeaman et al. in a flow cytometric analysis of C. albicans adherence to platelets in vitro, which indicated that these organisms bind directly to platelets in the absence of plasma (31). Our present results may be compared to those reported by Klotz et al., who showed that blastoconidia of C. albicans bound firmly to the surfaces of platelets aggregated by ADP whereas inactivated platelets did not adhere to yeast cells (15).
The reversibility of platelet binding to C. albicans blastoconidia by EDTA, EGTA, and sodium citrate suggests a cation-dependent link. In contrast these chelating agents did not modify the attachment of platelets to blastoconidia of other Candida species, suggesting that the mechanisms involved in the in vivo interaction of platelets with Candida cells may differ according to the species of Candida.
There is some discrepancy between our results and those of Klotz et al., who concluded that whole C. albicans cells are unable to aggregate platelets in vitro (15).
Other species of Candida have been shown to be able to cause platelet aggregation. It has been suggested that C. albicans does not aggregate platelets and is not killed by antimicrobial proteins released by activated platelets, implying a lack of recognition that may in fact contribute to the survival of this species (30). However, the presence of sodium citrate in the PRP might explain the nonadherence of platelets to C. albicans.
In conclusion, attempts to define the role of platelets in disseminated candidiasis have produced conflicting results. Further in vivo studies using variant strains should be carried out to determine whether the adherence of platelets to blastoconidia of C. albicans or other Candida species and the subsequent activation and aggregation of platelets are injurious or beneficial to the host.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported in part by grants from the Programme de Recherche Fondamentale en Microbiologie et Maladies Infectieuses et Parasitaires, Ministère de l'Education Nationale, de la Recherche et de la Technologie, Réseau Infections fongiques (RIF).
We thank Paulette Avranche for her technical assistance.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Groupe d'Etude des Interactions Hôte-Parasite, Laboratoire de Parasitologie-Mycologie, Faculté de Pharmacie, 16 Blvd. Daviers, 49000 Angers, France. Phone: (33)-02-41-22-66-62. Fax: (33)-02-41-48-67-33. E-mail: raymond.robert{at}univ-angers.fr.
Editor: T. R. Kozel
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Auriault, J. P., A. Capron, H. Vorn, and H. Viens. 1983. A new function for platelets: IgE-dependent killing of schistosomes. Nature 303:810-812[CrossRef][Medline]. |
| 2. | Biggerstaff, J. P., N. B. Seth, T. V. Meyer, A. Amirkhosravi, and J. L. Francis. 1998. Fibrin monomer increases platelet adherence to tumor cells in a flowing system: a possible role in metastasis? Thromb. Res. 92(Suppl. 2):S53-S58[CrossRef][Medline]. |
| 3. | Bouali, A., R. Robert, G. Tronchin, and J. M. Senet. 1986. Binding of human fibrinogen to Candida albicans in vitro: a preliminary study. J. Med. Vet. Mycol. 24:345-348[Medline]. |
| 4. |
Bouchara, J. P.,
G. Tronchin,
V. Annaix,
R. Robert, and J. M. Senet.
1990.
Laminin receptors on Candida albicans germ tubes.
Infect. Immun.
58:48-54 |
| 5. | Calderone, R., R. L. Cihlar, D. D. Lee, K. Hoberg, and W. M. Scheld. 1985. Yeast adhesion in the pathogenesis of endocarditis due to Candida albicans: studies with adherence-negative mutants. J. Infect. Dis. 152:710-715[Medline]. |
| 6. | Calderone, R., R. Diamond, J. M. Senet, J. Warmington, S. Filler, and J. E. Edwards. 1994. Host cell-fungal cell interactions. J. Med. Vet. Mycol. 32:151-168. |
| 7. | Clawson, C. C., and J. G. White. 1971. Platelet interaction with bacteria. I. Reaction phases and effects of inhibitors. Am. J. Pathol. 65:367-380[Medline]. |
| 8. | Edwards, J. E., T. A. Gaither, J. J. O'Shea, D. Rotrosen, T. J. Lawley, S. A. Wright, M. M. Frank, and I. Green. 1986. Expression of specific binding sites on Candida with functional and antigenic characteristics of human complement receptors. J. Immunol. 137:3577-3583[Abstract]. |
| 9. | Gilmore, B. J., E. M. Restinas, J. S. Lorentz, and M. K. Hostetter. 1988. An iC3b receptor on Candida albicans: structure, function, and correlates for pathogenicity. J. Infect. Dis. 157:38-46[Medline]. |
| 10. | Henderson, W. R. J. 1992. The role of the platelet in the pathogenesis of infectious diseases. Curr. Opin. Infect. Dis. 5:375-380[CrossRef]. |
| 11. |
Holder, I. A., and P. Nathan.
1973.
Effect in mice of viable Candida albicans and a cell-free sonic extract on circulating platelets.
Infect. Immun.
7:468-472 |
| 12. | Honn, K. V., D. G. Tang, and J. D. Crissman. 1992. Platelets and cancer metastasis: a causal relationship? Cancer Metastasis Rev. 11:325-351[CrossRef][Medline]. |
| 13. | Kates, M. M., J. B. Phair, M. Yungbluth, and S. C. Weil. 1988. Demonstration of Candida in blood smears. Lab. Med. 19:25. |
| 14. | Klotz, S. 1990. Adherence of Candida albicans to components of the subendothelial extracellular matrix. FEMS Microbiol. Lett. 68:249-254. |
| 15. | Klotz, S., J. Harrison, and R. Misra. 1989. Aggregated platelets enhance adherence of Candida yeasts to endothelium. J. Infect. Dis. 160:669-677[Medline]. |
| 16. |
Klotz, S.,
R. C. Hein,
R. L. Smith, and J. B. Rouse.
1994.
The fibronectin adhesin of Candida albicans.
Infect. Immun.
62:4679-4681 |
| 17. | Klotz, S., and R. L. Smith. 1995. Gelatin fragments block adherence of Candida albicans to extracellular matrix proteins. Microbiology 141:2681-2684[Abstract]. |
| 18. |
Maish, P. A., and R. A. Calderone.
1980.
Adherence of Candida albicans to a fibrin-platelet matrix formed in vitro.
Infect. Immun.
27:650-656 |
| 19. |
Maish, P. A., and R. A. Calderone.
1981.
Role of the surface mannan in the adherence of Candida albicans to fibrin-platelet clots formed in vitro.
Infect. Immun.
32:92-97 |
| 20. | Mehta, P. 1984. Potential role of platelets in the pathogenesis of tumor metastasis. Blood 1:55-63. |
| 21. | Miegville, M., and O. Morin. 1976. Observation de differentes souches de levures et de leurs protoplastes en microscopie électronique à balayage. C. R. Acad. Sci. Paris 283D:417. |
| 22. | Nosal, R., and Z. Menyhardtova. 1976. The effect of glycoprotein from Candida albicans on functions of rat platelets. Toxicon 14:313-318[Medline]. |
| 23. | Peyron, F., B. Polack, D. Lamotte, L. Kolodie, and P. Ambroise-Thomas. 1989. Plasmodium falciparum growth inhibition by human platelets in vitro. Parasitology 99:317-322. |
| 24. | Robert, R., C. Mahaza, M. Miegeville, J. Ponton, A. Marot-Leblond, and J. M. Senet. 1996. Binding of resting platelets to Candida albicans germ tubes. Infect. Immun. 64:3752-3757[Abstract]. |
| 25. | Robert, R., J. M. Senet, C. Mahaza, V. Annaix, et al. 1992. Molecular basis of the interactions between Candida albicans, fibrinogen and platelets. J. Mycol. Med. 2:19-25. |
| 26. | Rotrosen, D., R. A. Calderone, and J. E. Edwards. 1986. Adherence of Candida species to host tissues and plastic surfaces. Rev. Infect. Dis. 8:73-85[Medline]. |
| 27. | Scheld, W. M., and M. A. Sande. 1995. Endocarditis and intravascular infections, p. 740-783. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious diseases, 4th ed., vol. 1. Churchill Livingstone, New York, N.Y. |
| 28. | Skerl, K. G., R. A. Calderone, E. Segal, T. Sreevalsan, and W. M. Scheld. 1984. In vitro binding of Candida albicans yeast cells to human fibronectin. Can. J. Microbiol. 30:221-227[Medline]. |
| 29. |
Skerl, K. G.,
R. A. Calderone, and T. Sreevalsan.
1981.
Platelet interaction with Candida albicans.
Infect. Immun.
34:938-943 |
| 30. | Willcox, M. D. P., B. C. Webb, A. Thakur, and D. W. S. Harty. 1998. Interactions between Candida species and platelets. J. Med. Microbiol. 47:103-110[Abstract]. |
| 31. |
Yeaman, M. R.,
P. M. Sullam,
P. F. Dazin,
M. A. Ghannoum,
J. E. Edwards, and A. S. Bayer.
1994.
Fluconazole and platelet microbicidal protein inhibit Candida adherence to platelets in vitro.
Antimicrob. Agents Chemother.
38:1460-1465 |
| 32. |
Yeaman, M. R.,
A. S. Ibrahim,
J. E. Edwards,
A. S. Bayer, and M. A. Ghannoum.
1993.
Thrombin induced rabbit platelet microbicidal protein is fungicidal in vitro.
Antimicrob. Agents Chemother.
37:46-553 |
| 33. | Yeaman, M. R., S. S. Soldan, M. A. Ghannoum, J. E. Edwards, S. G. Filler, and A. S. Bayer. 1996. Resistance to platelet microbicidal protein results in increased severity of experimental Candida albicans endocarditis. Infect. Immun. 64:1379-1384[Abstract]. |
| 34. | Yeaman, M. R. 1997. The role of platelets in antimicrobial host defense. Clin. Infect. Dis. 25:951-970[Medline]. |
| 35. | Yeaman, M. R., Y. Q. Tang, A. J. Shen, A. S. Bayer, and M. E. Selsted. 1997. Purification and in vitro activities of rabbit platelet microbicidal proteins. Infect. Immun. 65:1023-1031[Abstract]. |
| 36. |
Yong, E. C.,
E. Y. Chi,
T. R. Fritsche, and W. R. Henderson.
1991.
Human platelet-mediated cytotoxicity against Toxoplasma gondii: role of thromboxane A2.
J. Exp. Med.
173:65-78 |
This article has been cited by other articles:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|